Your session is about to expire
← Back to Search
Local Anesthetic
bupivacaine for Labor Pain
N/A
Waitlist Available
Research Sponsored by Mark Kosanovich
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
adult pregnant women to age 45 with scheduled cesarean sections at Mercy Hospital and Medical Center
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post 120 minutes after arrival in the recovery room
Awards & highlights
Study Summary
This research will explore the question of whether preincisional skin infiltration with bupivacaine 0.25% decreases postoperative pain after Cesarean delivery.
Eligible Conditions
- Labor Pain
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 120 minutes after arrival in the recovery room
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~120 minutes after arrival in the recovery room
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Final score on the visual analogous scale
Secondary outcome measures
Analgesics
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: bupivacaineExperimental Treatment1 Intervention
Intervention
Group II: PlaceboPlacebo Group1 Intervention
Control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine
FDA approved
Find a Location
Who is running the clinical trial?
Mark KosanovichLead Sponsor
Rohitkumar Vasa, MDStudy ChairIRB Chair
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger